17-81665578-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039842.3(OXLD1):āc.67C>Gā(p.Arg23Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000505 in 1,583,372 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001039842.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OXLD1 | NM_001039842.3 | c.67C>G | p.Arg23Gly | missense_variant | 2/2 | ENST00000374741.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OXLD1 | ENST00000374741.4 | c.67C>G | p.Arg23Gly | missense_variant | 2/2 | 1 | NM_001039842.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 23AN: 224180Hom.: 0 AF XY: 0.0000978 AC XY: 12AN XY: 122648
GnomAD4 exome AF: 0.0000468 AC: 67AN: 1431096Hom.: 0 Cov.: 31 AF XY: 0.0000508 AC XY: 36AN XY: 707976
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.67C>G (p.R23G) alteration is located in exon 2 (coding exon 2) of the OXLD1 gene. This alteration results from a C to G substitution at nucleotide position 67, causing the arginine (R) at amino acid position 23 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at